activity of dabrafenib/trametinib combo in patients with melanoma brain metastases
Published 7 years ago • 432 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
1:19
dr. robert on potential of dabrafenib/trametinib in melanoma brain metastases
-
2:12
phase iii combi-d study of dabrafenib and trametinib in patients with melanoma
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
0:53
dabrafenib plus trametinib demonstrates benefit in braf-mutant melanoma
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
1:03
five-year os data for dabrafenib/trametinib combo in melanoma
-
1:04
dr. wilson on long-term data with dabrafenib plus trametinib in melanoma
-
3:05
dabrafenib and trametinib: a promising combination for the treatment of melanoma
-
6:43
managing brain metastases in melanoma
-
5:26
updates in melanoma: treating braf and brain metastases
-
1:27
bgb324 with pembrolizumab or dabrafenib/trametinib in melanoma
-
1:08
fda approval of adjuvant dabrafenib/trametinib in braf melanoma
-
0:59
the success of the dabrafenib and trametinib combination in braf-mutated melanoma
-
2:02
targeted therapies for melanoma treatment: a round-up of the important data presented at asco 2017
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
2:46
long-term outcomes with dabrafenib plus trametinib in braf v600-mutant melanoma
-
5:48
clinical experience with dabrafenib/trametinib in nsclc
-
1:03
dr. long on nivolumab/ipilimumab in patients with melanoma brain metastases
-
5:40
managing brain metastases and side effects in melanoma